How a global pandemic fueled cold chain innovation

Update : 18th March, 2021

What: Temperature Controlled Logistics Europe Conference

When: 24th-25th March 2021

Where: Virtually

For who: Cold chain users and solution providers including pharma and biotech companies, as well as validation, shipping, packaging and labeling providers.

Why: Temperature sensitive drugs have unprecedented relevance of late and this year the event is hosted on a brand new 2021 virtual platform (based on user feedback) that will enable attendees to truly make the most of this multiple decade event.

How a global pandemic fueled cold chain innovation

The vital nature of temperature controlled logistics (when drugs need to be kept at a specific temperature during transport/storage) has been brought into heightened public awareness this year with Covid vaccines requiring storage.

The temperature range is typically between 2-8 degrees Celsius. However there are outliers like the Pfizer vaccine, which requires a temperature of minus 70, introducing a new set of logistical challenges.

This is another example of how a global pandemic has fueled faster paced innovation than we’ve previously seen in cold chain logistics.

While not limited to a focus on Covid vaccines, this event will incorporate the progress of the past year into a solution based, innovative virtual event entitled Temperature Controlled Logistics Europe Conference on 24th-25th March 2021.

Event Highlights and Topics

This event will assess how to reduce the risk of temperature excursions when shipping biologics, how to use data to effectively monitor temperatures and avoid excursions, and reveal what the last 3 months of Brexit regulations have taught us about cold train transport. It also offers the latest tools and strategies for a post pandemic transport landscape.

Sessions of interest may include: Javier Garcia Vela, Transport and Logistic Services Team Lead at Roche will provide a session on 'Monitoring and Controlling Temperature for Direct-to-Patient Shipments'.

K Nicole Harter, Quality Consultant, Global Logistics, Quality Systems, Laboratories at Eli Lilly and Company will present on "Using Data Effectively to Monitor Temperature and Avoid Excursions".

Georges L. France, VP, Quality Integration Lead at GSK will give a presentation on 'How the New ICH Quality Guidelines May Facilitate Innovation and Flexibility (Benefits and Challenges)'.

Delegates will find mixture of presentations, panel discussions and roundtables with Clover Biopharmaceuticals, Eli Lilly and Company, Sagent Pharmaceuticals, Merck, the Centre for Supply Chain Innovation, GSK and more.

Enhanced virtual technology

Arena is now hosting virtual events on a new 2021 virtual platform.

“We’ve taken feedback on engagement and booth traffic interaction and rebuilt the virtual platform from the ground up,” says Arena Events. “If people can’t speak to each other effectively, we aren’t adding value to attendance. We left third party platforms behind, tested and rolled out a product that trial sponsors and delegates alike love because it’s simple to use and ultimately best mimics the real time traffic and engagement of a live event.”

Delegates can register at: https://www.eventsonlineregister.com/tc-events/temperature-controlled-logistics-in-biopharmaceuticals-2020-a-virtual-experience/

About Arena International

Each year, over 10,000 business executives from Fortune 1000 companies attend over 80 Arena International events worldwide, addressed by over 1,700 industry leaders delivering leading edge content and discussion. We identify the pioneering case studies, innovative solutions and up-to-the-minute discussion topics that comprise programmes of wholly unbiased integrity.

Arena International events group (part of Global Data) bring together sponsors and delegates in a way that maximizes business outcomes and professional standing, by providing uncompromised value rooted in business intelligence.

http://www.arena-international.com

Contact:
Melissa Porter
Digital Marketing
T +44 (0) 7720831416
E Melissa.porter.ctr@globaldata.com


This news article complies with our Editorial Policy